Most Popular Stories
- Study: Current EMRs don't have measurable impact on cost or quality
- AMIA 09: CHCF president calls for more 'Kaiserness' to connect information
- Electronic claims submission could save $11B per year
- UnitedHealth Group (UNH) Q3 Results - Q3 Top Health Insurance Company Earnings Report
- Carolyn Byerly - Fierce Women to Watch in Health IT
- Senators ponder varied tax increases, including non-profit hospital tax
Featured Jobs
-
Urologist for California
StaffPointe, LLC - Bay area , CA -
Pain Medicine Job in Pennsylvania
StaffPointe, LLC - south of Erie, PA -
Perinatologist Job in Tennessee
StaffPointe, LLC - Memphis, TN -
Internal Medicine Job in Tennessee
StaffPointe, LLC - west, TN -
Nurse Practitioner Job in Louisiana
StaffPointe, LLC - near coast, LA
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010 - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- prescription drugs
- health reform
- pharmaceutical companies
Grassley investigates Pfizer's financial ties to Harvard Med School MDs
Sen. Charles Grassley (R-IA) continues with his campaign to address pharma influence in medicine, this time with a letter to Pfizer asking about its financial relationship with doctors at Harvard Medical School. The letter follows on intensifying protests among medical students, many of whom object to what they see as excessively close ties between the school and industry.
In the letter, Grassley asks Pfizer to provide a detailed accounting of payments or any other benefits the company might have given to 149 Harvard faculty members mentioned in a recent New York Times article, as well as any other unreported Harvard physicians who might have gotten paid by Pfizer. The article Grassley mentions discusses how students at Harvard have started questioning the school's overall financial ties to the drug business.
The plot thickened yesterday when, as mentioned in the Times article, a Pfizer employee took cellphone pictures of students protesting over faculty drug industry relationships. Grassley, who isn't having any of this either, is also asking Pfizer to send any "emails, faxes, letters, and photos regarding Harvard medical students demonstrating and/or agitating against pharmaceutical influence in medicine." (What does Pfizer intend to do with the photos--bar the students from getting fat pharma consulting contracts when they graduate?)
To learn more about the dispute:
- read this Wall Street Journal piece
Related Articles:
Harvard psychiatrists fail to reveal millions in pharma pay
Harvard Med School strengthens conflict-of-interest rules
Study: Academic medical centers have easier time with conflict-of-interest policies
Drug company funding for universities under more pressure
Related Stories
- Conflict-of-interest policies for med schools a mixed bag
- Tufts withdraws invitation for Grassley aide to speak
- Trial data on Neurontin may have been manipulated
- Orthopedic doctors resist disclosing consulting fees
- Hope for public option remains, despite Senate set-back
- Paul Levy - 9 People to Watch in Healthcare
- Atul Gawande - 9 People to Watch in Healthcare
- SPOTLIGHT: Aides working on reform have health industry connections
- Pfizer pays $2.3B penalty for off-label drug marketing
- Trend: More than half of primary-care doctor grads are immigrants
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





